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Summary The sudden evolution of catheter ablation (CA) therapy for atrial ﬁbrillation (AF)
was brought by the discovery of a new insight into the triggering mechanism of AF by Haïs-
saguerre et al. in 1998. This discovery opened a new era of evolution of ablation therapy
of paroxysmal AF (PAF). At the frontier of AF ablation, technical development of CA for
long-standing persistent AF (CAF) has been done enthusiastically, although the detailed elec-
trophysiologic mechanism and anatomical substrate of persistent AF remain unknown. Stepwise
ablation composed of multiple procedures, circumferential pulmonary vein isolation (PVI), bia-
trial defragmentation, and anatomical linear ablation with the endpoint of AF termination has
been the most widely accepted method, because the efﬁcacy of this method was reported
to be surprisingly high during a relatively short duration of follow-up. Recently, they showed
this strategy has a signiﬁcant limitation in efﬁcacy for CAF with long AF duration (>7 years),
enlarged left atrium (>50mm in left anterior descending artery), short AF cycle length (AFCL)
(<130ms) and impaired cardiac function. For cases associated with these clinical, anatomical,
and electrophysiological parameters, AF termination as an endpoint might be abandoned if
peak prolongation of AFCL, reduction of intra-/inter-atrial AFCL gradient, and low deﬁbrilla-
tion threshold are attained after predetermined lesion set is completed. Prolonged procedure
with massive tissue ablation to attain AF termination should be avoided, because it potentially
increases adverse events during and immediately after the procedure and causes extensive
scar-formation in both atria with atrial mechanical dysfunction.
© 2011 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.
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Predetermined  Linear Ablation at CFAE-Prevalent Areas for CAF
: Tsuchiura Method
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Figure 1 Scheme of stepwise predetermined linear abla-
tion targeting CFAE-prevalent areas for chronic AF. Stepwise
bi-atrial ablation composed of extensive encircling pulmonary
vein isolation and predetermined linear ablation at already
known CFAE-prevalent areas. Steps 1—6 are performed step-
wise until the endpoint of termination of on-going AF. AF, atrial
ﬁbrillation; CFAE, complex fractionated electrogram; LA, left
atrium; RA, right atrium; LAA, left atrial appendage; RAA,
right atrial appendage; RS/RI/LS/LIPV, right superior/right infe-
rior/left superior/left inferior pulmonary vein; Sept, septum;
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trial ﬁbrillation (AF) is the most common arrhythmia par-
icularly in the aged population with an incidence of 4%
fter the age of 65 with doubling of it as the age advances
very 10 years [1]. Strong associations are known between
F and increased risk of cerebral embolism/stroke, all types
f dementia, development of heart failure, and increased
ortality. Persistence of left atrial (LA) volume and pres-
ure overloading during AF due to loss of atrial contraction,
hortened diastolic ventricular ﬁlling, and atrio-ventricular
alvular regurgitation leads to an atrial anatomical and elec-
rical remodeling which further facilitates persistence of
F. The Canadian Registry of AF reported that the proba-
ility of progression of paroxysmal AF (PAF) to chronic AF
CAF) (deﬁned as AF on 2 consecutive electrocardiograms
eparated by ≥1 week) was 8.6% by 1 year [2]. This malig-
ant cycle should be interrupted immediately by restoring
f sinus rhythm (SR) and its long-lasting maintenance.
New on-treatment analysis of the AFFIRM study revealed
hat presence of SR was associated with a 47% reduction in
eath and use of antiarrhythmic drugs (AAD) was associated
ith signiﬁcant increase of mortality by 49% [3]. This sug-
ests that the favorable effects of AAD on AF termination
ight be offset by their potentially life-threatening adverse
ffects, and minimally invasive non-pharmacological treat-
ent with acceptable risks, in other words catheter ablation
CA) must be ﬁrst-line therapy. Superiority of CA to AAD in
F rhythm control has been shown by recent meta-analyses.
he recent meta-analysis of randomized, controlled trials
omparing pulmonary vein isolation (PVI) and medical ther-
py by Piccini et al. [4] showed markedly higher AF-free
urvival rate at 1 year in CA (77% vs 29%). According to that
y Calkins et al. [5], multiple CA showed higher efﬁcacy of
A (71% vs 52%) and also lower rate of adverse effects (5%
s 30%).
The sudden evolution of catheter ablation (CA) therapy
or AF was brought by the discovery of a new insight into trig-
ering mechanisms of AF by Haïssaguerre et al. in 1998 [6].
hey reported that the most cases of PAF were initiated by
ulmonary vein (PV) triggers, and PAF can be cured by abla-
ion of PV triggers. Immediately after, they originated a new
trategy of electrical PVI for cure of PAF, which was invented
o increase the efﬁcacy and decrease the risk of collateral
amages [7]. The PVI technique was modiﬁed and improved
o isolate wide area surrounding PV antrum by encircling
inear lesions, which brought not only electrical isolation
ffect of PV ﬁring but also substrate modiﬁcation or isola-
ion effect for AF initiation and maintenance. This type of
VI is associated with better therapeutic outcomes by addi-
ional substrate modiﬁcation effect addition and with less
isk of PV stenosis and is considered to be a cornerstone of
A of AF according to a recent expert consensus statement
8].
c
r
w
sO, fossa ovalis; CSO, coronary sinus ostia; SVC, superior vena
ava; IVC, inferior vena cava; TA, tricuspid annulus; TA, tricus-
id annulus; CT, crista terminalis; CTI, cavotricuspid annulus.
lectrophysiologic bases and effects for
xtensive encircling/circumferential PVI
F initiation and perpetuation require both AF triggers and
usceptible substrates. Although the PVI technique was orig-
nally invented to eliminate AF triggers, it is now well
ccepted that circumferential ablation with or without PVI
an modify and also isolate the susceptible substrates for AF
nitiation and perpetuation from the following ﬁndings. (1)
ersistent AF can be terminated by line ablation at the junc-
ion between arrhythmogenic PV and LA before achievement
f complete electrical disconnection. (2) Inducibility of
ustained AF by programmed electrical stimulation is signif-
cantly decreased after achievement of extensive encircling
VI (EEPVI). (3) Sustained intra-PV tachycardia can be
nduced by programmed electrical stimulation inside the
Vs and surrounding LA tissue disconnected from the LA.
4) After achievement of EEPVI, intra-PV tachycardia which
s similar to that functioning as AF driver before isolation
an occur spontaneously or be induced. (5) Regions with
apid regular tachycardia as potential AF driver and those
ith ﬁbrillatory activity as potential AF substrate can coexist
imultaneously in the extensively isolated area (Fig. 1).
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eFrontier of AF ablation
EEPVI or circumferential-PVI (CPVI) associated with sub-
strate modiﬁcation or isolation effect as written above
proved to be very effective for PAF and a part of persis-
tent AF with duration for weeks and months. Concerning
PAF, the efﬁcacy rate of CA is reported to be from 40 to 70%
after single procedure and 65 to 90% after multiple proce-
dures. In comparison of CA with pharmacological therapy,
deﬁnite superiority of CA to AAD treatment for restoration
of SR has been reported by multiple single center trials and
meta-analysis studies [4,5]. In this context, applications of
CA for AF have spread rapidly and are widely associated with
reﬁnements of techniques and devices for it.
AT the frontier of CA for AF, many investigators are con-
cerned about the development of new ablation strategies
of CA for long-standing persistent AF and the induction of
new devices and energy sources to make intended abla-
tion lesions precisely, easily, and safely. A three-dimensional
electrical and anatomical (3D-EA) mapping device is useful
for navigation of catheter manipulation without full-time
ﬂuoroscopic guidance and it can register ablation points.
The cooling ablation system with irrigation catheter can
enhance ablation effect and reduce thromboembolic forma-
tion. These technological developments contributed to the
advancement of complex ablation for CAF by the increment
of its effectiveness and safety.
Newly developed ablation strategies for
substrate modiﬁcation for persistent AF
The development of PVI for CA of AF opened the era of
widespread CA and also gave us a new understanding of
the AF mechanisms from the point of view of AF trig-
gers for its initiation and AF substrate for its maintenance.
As written before, the EEPVI/CPVI linear lesion made at
border between the PV antrum and LA posterior wall to
isolate PVs shows substrate modiﬁcation effect in addition
to isolation of AF triggers and effectiveness for termina-
tion of persistent AF with duration for weeks and months.
However, any type of PVI alone is usually ineffective for
long-standing persistent AF (CAF deﬁned as persistent AF
1 year’s duration) with duration for years. In this situation,
additional ablation procedures associated with EEPVI/CPVI
were developed for substrate modiﬁcation. Haïssaguerre
et al. induced additional linear ablation anatomically local-
ized at the mitral isthmus and anterior LA roof following
maze surgery after PVI in a case with sustained AF that
remained inducible after PVI [9—11]. They obtained a cer-
tain amount of improvement in ablation results by adding
linear ablation. However, they had to recognize the chal-
lenging nature of linear ablation to attain the endpoint of
complete conduction block, limited success rate, and rel-
atively high complication rate [9—11]. Nademanee et al.
[12—14] advocated a new substrate ablation technique,
electrogram guided approach. They targeted the areas of
complex fractionated atrial electrogram (CFAE) for sub-
strate modiﬁcation. They deﬁned CFAE as low voltage atrial
electrograms (ranging from 0.04 to 0.25mV) with at least
one of the following ﬁndings, fractionation with ≥2 deﬂec-
tions, continuous activity, and short cycle-length activity
with cycle length ≤120ms [12—14]. They ablated CFAE areas
based on the hypothesis that CFAE might reﬂect slow conduc-
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ion, conduction block, pivot points, and rotors as critical
arts of random reentry during AF. Their recent results of
40 AF patients with a mean follow-up period of 839± 493
ay showed that SR was maintained in 93% (208/224) of PAF,
7% of persistent AF (138/176), and 78% (138/176) of perma-
ent AF on AAD [13,14]. According to their successful results,
ure CFAE-guided bi-atrial ablation prevailed as AF substrate
odiﬁcation strategy.
tepwise ablation for long-standing AF
aïssaguerre et al. [15,16] ﬁrst reported stepwise ablation
s a new ablation strategy for long-standing AF (CAF) in
005. For CAF patients, stepwise ablation is performed dur-
ng on-going AF under AF cycle length (CL) monitoring and
ith the endpoint of termination of persistent AF, based
n the hypothesis that AFCL prolongation and AF termi-
ation are indicators of reduction and eradication of AF
ubstrate respectively [15,16]. PVI is done at the ﬁrst step
nd consequently electrogram-based atrial area ablation
nd anatomy-based linear ablation as substrate modiﬁcation
f persistent AF. Their substrate modiﬁcation strategy under
he monitoring of AFCL is supported by their own hypoth-
sis that in persistent AF multiple microreentrant sources
rotors) act as reservoirs continually refueling persistent
brillation processes and CFAE represents rotors and ﬁbril-
atory conduction at surrounding areas with connection to
otors, and AFCL can be a marker of AF substrate burden
17]. Their criteria of CFAE as target electrograms include
iscrete local electrical activity with activation gradient
nd constant conduction sequence from distal to proximal
r vice versa direction between 2 adjacent bipolar elec-
rograms besides fractionated activity, rapid activity, and
ontinuous activity deﬁned by Nademanee et al. [12—14].
heir lesion set is composed of PVI as the ﬁrst step, ablation
t CFAE recording areas (LA defragmentation) on the LA sep-
um, inferior LA along the coronary sinus (CS), in the CS, the
ase of LA appendage (LAA), and then defragmentation in
he right atrium (RA) optionally if AFCL in RA remains shorter
han that in LA as the second step, and linear ablation at
he LA roof, and mitral isthmus as the third step [15,16].
heir initial papers in 2005 reported long-standing persis-
ent AF in 60 patients with a mean duration of 17 months
as terminated during ablation in 87% (directly to SR in 13%
therwise to AT in 74%), and in AF-terminated patients SR
as maintained for 11 months without AAD-on.
Following their strategy, Rostock et al. [18] and O’Neill
t al. [19] reported the signiﬁcantly beneﬁcial effects of
trial defragmentation strategy to obtain and maintain SR
n long-standing persistent AF. At present, stepwise abla-
ion composed of PVI, CFAE-guided LA/RA ablation, and
natomy-guided linear ablation is the most prevailing strat-
gy for CAF.
ontroversial interpretations and presumed
lectrophysiological bases of CFAEhe electrophysiologic interpretations and presumed bases
f CFAE remain to be investigated. Nademanee et al.
12—14] originally introduced CFAE as a marker of atrial
ubstrate in AF ablation and CFAE-guided LA/RA ablation
102 Y. Iesaka
Figure 2 Extensive encircling pulmonary vein isolation
(EEPVI) by roadmap application of three-dimensional electrical
and anatomical (3D-EA) mapping (Carto system). Bilateral EEPVI
was done under navigation by roadmap application of 3D-EA
mapping, Carto system. Posterior ablation points are registered
by dark red tags and anterior ablation points are registered
by pink tags in the open space. White tag indicates ablation
point accomplishing pulmonary vein isolation, and grey tags
indicate additional ablation points or registered points of scar
without ablation. In this case, left-sided and right-sided supe-
rior and inferior pulmonary veins were simultaneously isolated,
which was shown by sudden disappearance of intra-pulmonary
vein potentials. II/V1, surface electrocardiogram in lead II and
V1; ABL, ablation catheter; RF-on, radiofrequency energy on;
RSPV/RIPV/LSPV/LIPV, right superior/right inferior/left supe-
rior/left inferior PV; CS, coronary sinus; AP, antero-posterior;
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Figure 3 All the ablation points made by stepwise lin-
ear ablation (Tsuchiura method) are displayed on the outer
and inner views of merged three-dimensional CT images.
AP, antero-posterior; PA, postero-anterior; RAO, right anterior
oblique; LAO, left anterior oblique; LAA, left atrial appendage;
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ablation and additional defragmentation with the endpointAO, left anterior oblique.
s widely utilized solely or in conjunction with PVI and/or
natomy-guided linear ablation. Their method was based on
he hypothesis that CFAE reﬂects slow conduction, conduc-
ion block, wave-front collision, pivot points of critical parts
uring reentry supported by the classic ﬁndings by Konings
t al. [20], which was recorded in the RA of Wolff-Parkinson-
hite syndrome patients during electrically induced AF.
alifa et al. [21] reported in isolated sheep heart model
uring acetylcholine-induced AF, rapid regular activity at
entral anchoring point of rotor and fractionated activity
ue to ﬁbrillatory conduction from rotor at its surrounding
reas. As the other bases of CFAE, autonomic innervations
nd their hyper-activations at the cardiac ganglionated plexi
ave been reported to generate CFAE at all PV antrum areas
22].
Recently, Narayan et al. [23] analyzed the CFAE using
onophasic action potential (MAP) recording in patients
ndergoing AF ablation, and described very interesting
ndings. They found rapid and discrete MAPs potentially
epresenting areas of rotors of AF only in 8% of all CFAE
reas, and vast majority far-ﬁeld MAPs superimposed on
ocal discrete MAPs at the areas composed of overlap-
ing atrial myocardial layers such as interatrial septum
nd CS of which ablation may often slow, organize, and
erminate AF.
o
c
(S/LI/RS/RIPV, left superior/left inferior/right superior/right
nferior pulmonary vein.
Several pathologists [24] have proposed the hypothe-
is that anisotropic reentry between overlapping multiple
yocardial ﬁbers could lead to the electrophysiological basis
f CFAE. The myocardial architecture of the LA wall shows
he composition of multiple overlapping muscle bundles
hich include interatrial (Bachmann bundle), septoatrial,
nd septopulmonary bundles particularly on the roof, ante-
ior wall, interatrial septum, the border of PV antrum, the
ase of LAA and inferior LA along CS [24]. To be noticed,
hese complex myocardial architectural sites are well iden-
ical to the sites characterized by CFAE recording as reported
y many publications.
urrent ablation strategies for long-standing
F or CAF
he promising result of Nademanee method [12—14] by tar-
eting CFAE-sites in both atria without additional ablation
trategy has not been reproduced in PAF and CAF patients
t present by other groups [25,26]. However, CFAE-guided
blation as an additional strategy for substrate modiﬁca-
ion in conjunction with PVI has been reported to improve
rocedural outcome compared with PVI alone by several
nvestigators [27,28]. Also stepwise ablation strategies orig-
nated by Haïssaguerre et al., which are composed of PVI,
trial defragmentation, and linear ablation showed very high
fﬁcacy and their good outcome is reproduced by other
roups. Rostock et al. [18] reproduced similar results.
In 2002, EEPVI was developed at Tsuchiura Kyodo Hospi-
al by the current author and co-workers [29], and later we
tarted stepwise ablation strategy for CAF, which was com-
osed of EEPVI and predetermined biatrial anatomical linearf AF termination or AF conversion to stable atrial tachy-
ardia (AT) [30] (Fig. 1). At the ﬁrst step, EEPVI is done
Fig. 2) and then predetermined linear lesions are produced
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Figure 4 A case of long-standing persistent atrial ﬁbrillation terminated and converted to sinus rhythm during ablation at
CFAE(complex fractionated atrial electrogram)-recording site of the base of the LAA. To be noticed, persistent atrial ﬁbrillation was
terminated by ablation at the base of left tria appendage with regular rapid activities (cycle length shorter than 110ms) recorded.
LAA, left atrial appendage; II/V1, surface electrocardiogram in lead II/V1; RA, right atrium; Abl, ablation catheter; LSPV/LIPV, left
entri
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Wsuperior pulmonary vein/left inferior pulmonary vein; RV, right v
oblique; HRA, high right atrium.
stepwise at the LA roof and bottom between the tops and
bottoms of bilateral, on the LA septum, along the CS and
mitral annulus between 6 and 3 o’clock, on the mitral isth-
mus, along the base of LAA and optionally in the right atrial
septum and along the crista terminalis and the base of
appendage (Fig. 3). The backgrounds underlying our ablation
strategy are recent knowledge concerning the distribution of
CFAE areas [23], and established efﬁcacy of maze-procedure
[31]. The areas where we make linear lesions are identical
to those where CFAE are very high-incidentally identiﬁed
due to many reports, and there is evidence that the maze-
procedure brought successful outcomes in conversion of CAF
into SR by making linear lesions in both atria [31].
In the Tsuchiura method, a 3D-EA map (Carto system) is
used to navigate ablation and to check the integrity and
continuity of lesions as shown in Figs. 2 and 3. During the
stepwise procedure, AF can be converted directly into SR
(Fig. 4) or through intermediate AT (Figs. 5 and 6). At the
ﬁrst session AF is converted into SR in 24% of the patients
and AF is converted into AT in 17% of the patients predomi-
nantly during ablation at the LA septum, along the CS and the
base of LAA in consecutive 218 CAF patients with a median
and mean AF duration of 36 and 69 months, respectively
(Fig. 7). If AF cannot be terminated by completion of our
lesion set, AF is terminated by internal electrical cardiover-
sion using a 6F 7+7-polar catheter (Inquiry, St. Jude Medical,
St. Paul, MN, USA) introduced in the CS [30]. The second ses-
sion was performed in 19% of the patients in AF termination
group for recurrent AT (80%) and AF (20%), while in 44% in AF
g
5
e
ccle; CS, coronary sinus; AP, antero-posterior; LAO, left anterior
on-termination group for recurrent AF (50%) and AF (50%).
uring 16± 9 follow-up months, AF/AT free rate is 86% in AF
ermination group, 66% in AF no termination group, and 74%
n total patient group (Fig. 7).
ecision of endpoint of CAF ablation
ccording to the reports from Haïssaguerre et al. [15,16],
ostock et al. [17], and O’Neil et al. [18], termination of
hronic AF can be achieved during ablation with a very
igh incidence of 77% to 87% and AF termination is con-
luded to be an appropriate endpoint of ablation for CAF.
owever, it is controversial whether AF termination during
blation is associated with an excellent outcome. O’Neil et
l. [18] reported that multivariate logistic regression analy-
is showed AF termination was associated with longer AFCL
t baseline (150ms), shorter duration of AF (12 months),
nd smaller LA size (LAD) (47mm). Our data also show the
ame result as O’Neil et al. [17], and moreover the impact
f AF termination on good outcome is limited only on CAF
ith relatively short duration less than three years.
As written above, we give internal electrical cardiover-
ion using special 7+7-polar catheter placed in the CS [30].
e could measure atrial deﬁbrillation threshold (DFT) by
iving DC shock with an initial energy setting of 5J and then
J step’s increment between proximal and distal 7-polar
lectrodes placed in the RA and CS respectively until suc-
essful cardioversion [29]. Our study showed a comparable
104 Y. Iesaka
Figure 5 Long-standing persistent AF was converted to left-sided AT due to peri-mitral reentry by ablation at posterior LA septum
with rapid activities recorded. II/V1, surface electrogram in lead II and V1; HRA, high right atrium; ABLp, ablation catheter proximal;
A left
a ue.
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sBLd, ablation catheter distal; RF, radiofrequency energy; LAA,
trial tachycardia; AP, antero-posterior; LAO, left anterior obliq
rrhythmia-free rate between patients who achieved proce-
ural AF termination and those who underwent successful
lectrical cardioversion at low DFT ≤10J after comple-
ion of our predetermined steps. Additionally, in low DFT
atients, the majority of recurrent arrhythmia after the ini-
ial session is organized AT, which is similar to the patients
(
c
o
a
igure 6 Peri-mitral reentry AT converted from baseline AF as sh
y intra-coronary sinus (epicardial) ablation after multiple endocard
isplayed on the merged 3D-CT ﬁgure with blue endocardial and gre
n lead II and V1; HRA, high right atrium; ABL, ablation catheter; p,
uperior/left inferior/right inferior pulmonary vein; AP, antero-postatrial appendage; CS, coronary sinus; AF, atrial ﬁbrillation; AT,
ith AF terminated during procedure and suggests effec-
ive AF substrate modiﬁcation is achieved by our lesion set
Fig. 8). Lower DFT can be utilized as a predictor of out-
ome, and can be an indicator to determine the endpoint
f the procedure in patients with AF that remains persistent
fter predetermined stepwise ablation particularly in CAF
own in Fig. 5 was terminated and successfully ablated ﬁnally
ial ablation. All the ablation points on the mitral isthmus were
en epicardial ablation points. II/V1, surface electrocardiogram
proximal; d, distal; LAA, left atrial appendage; LS/LI/RIPV, left
erior; LAO, left anterior oblique.
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Figure 7 Kaplan—Meier curve analysis of AT/AF-free survival rate after the last ablation by Tsuchiura method. In 218 consecutive
CAF patients with median AF duration of 36 months and mean AF duration of 69 months, AF was terminated by catheter ablation
in 41% of patients. All the patients were followed up during 16± 0.6 months after the last session (mean 1.5± 0.6 sessions). AF/AT
free rate in AF termination group is 86% and 66% in AF non-terminati
AT, atrial tachycardia; LAD, left atrial diameter.
patients associated with longer duration of AF and larger LA
dimensions [30].
In the ablation procedure for long-standing persistent
AF, the endpoint of stepwise ablation procedure remains to
be urgently investigated and deﬁned. It is technically very
difﬁcult to eliminate all local CFAE electrograms widely dis-
tributed all over both atria and make linear lesions with
complete conduction block. Such extensive ablation poten-
tially causes prolonged procedure time, increased risk of
Figure 8 Kaplan—Meier curve analysis of AF/AT-free survival
rate after the last session. Low deﬁbrillation threshold (DFT)
group showed high AF/AT-free rate after the last session nearly
equal to AF termination group. AF, atrial ﬁbrillation; AT, atrial
tachycardia; DFT, deﬁbrillation threshold; J, joul.
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Ron group. Over-all AF/AT free rate is 74%. AF, atrial ﬁbrillation;
rocedural complications and damage of long-term atrial
echanical function.
onclusion
t the frontier of AF ablation, technical development of
A for long-standing persistent AF (CAF) has been done
nthusiastically, although the detailed electrophysiologic
echanism and anatomical substrate of AF persistence
emained to be clariﬁed. Stepwise ablation composed of
ultiple procedures, circumferential PVI, biatrial defrag-
entation, and anatomical linear ablation with the endpoint
f AF termination developed is the most widely accepted and
erformed.
However, this strategy has signiﬁcant limitation in efﬁ-
acy for CAF with long AF duration (>7 years), enlarged LA
>50mm in LAD), short AFCL (<130ms), and impaired cardiac
unction. In cases associated with these clinical, anatomical,
nd electrophysiological parameters, AF termination as an
ndpoint might be abandoned if peak prolongation of AFCL,
eduction of intra-/inter-atrial AFCL gradient and low DFT
re attained after predetermined lesion set. A prolonged
rocedure with massive tissue ablation to attain AF termi-
ation potentially increases adverse events and extensive
car-formation with future atrial mechanical dysfunction.
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